Abstract
The aim of the present study was to evaluate the effects of an exercise training program on lipid profile and composition of high-density lipoprotein (HDL) subfractions in systemic lupus erythematosus (SLE) patients and healthy controls. A 12-week, randomized trial was conducted. Thirty-three physically inactive SLE patients were randomly assigned into two groups: trained (SLE-TR, n = 17) and non-trained (SLE-NT, n = 16). A gender-, BMI-, and age-matched healthy control groups (C-TR, n = 11) also underwent the exercise program. Subjects were assessed at baseline (Pre) and 12 weeks after the 3-month exercise training program (Post) for lipid profile (HDL, low-density lipoprotein, very low-density lipoprotein, and total cholesterol and triglycerides levels) and composition of the HDL subfractions HDL2 and HDL3. SLE patients showed significantly lower contents of Apo A-I, phospholipid, and triglyceride in the HDL3 subfraction (p < 0.05, between-group comparisons) than healthy controls at baseline. The exercise training program did not affect any of the parameters in the SLE-TR group (p > 0.05, within-group comparisons), although there was a trend toward decreased circulating Apo B levels (p = 0.06, ES = −0.3, within-group comparison). In contrast, the same exercise training program was effective in increasing contents of cholesterol, triglyceride, and phospholipid in the HDL2 subfraction in the C-TR group (p = 0.036, ES = 2.06; p = 0.038, ES = 1.77; and p = 0.0021, ES = 2.37, respectively, within-group comparisons), whereas no changes were observed in the composition of the HDL3 subfraction. This study showed that SLE patients have a less effective response to a 12-week exercise training program than healthy individuals, with regard to lipid profile and chemical composition of HDL subfractions. These results reinforce the need for further studies to define the optimal training protocol to improve lipid profile and particularly the HDL composition in these patients (registered at clinicaltrials.gov as NCT01515163).
Similar content being viewed by others
References
Bartels CM, Buhr KA, Goldberg JW, Bell CL, Visekruna M, Nekkanti S, Greenlee RT (2014) Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort. J Rheumatol. doi:10.3899/jrheum.130874
Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE (2003) Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2399–2406. doi:10.1056/NEJMoa035471
Arca M, Pigna G, Favoccia C (2012) Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr Vasc Pharmacol 10(6):684–686
de Carvalho JF, Bonfa E, Borba EF (2008) Systemic lupus erythematosus and “lupus dyslipoproteinemia”. Autoimmun Rev 7(3):246–250. doi:10.1016/j.autrev.2007.11.016
Asanuma Y, Oeser A, Shintani AK, Turner E, Olsen N, Fazio S, Linton MF, Raggi P, Stein CM (2003) Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 349(25):2407–2415. doi:10.1056/NEJMoa035611
Chung CP, Oeser A, Raggi P, Solus JF, Avalos I, Linton MF, Fazio S, Stein CM (2008) Lipoprotein subclasses and particle size determined by nuclear magnetic resonance spectroscopy in systemic lupus erythematosus. Clin Rheumatol 27(10):1227–1233. doi:10.1007/s10067-008-0890-4
Juarez-Rojas J, Medina-Urrutia A, Posadas-Sanchez R, Jorge-Galarza E, Mendoza-Perez E, Caracas-Portilla N, Cardoso-Saldana G, Munoz-Gallegos G, Posadas-Romero C (2008) High-density lipoproteins are abnormal in young women with uncomplicated systemic lupus erythematosus. Lupus 17(11):981–987. doi:10.1177/0961203308093072
McMahon M, Grossman J, FitzGerald J, Dahlin-Lee E, Wallace DJ, Thong BY, Badsha H, Kalunian K, Charles C, Navab M, Fogelman AM, Hahn BH (2006) Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 54(8):2541–2549. doi:10.1002/art.21976
McMahon M, Skaggs BJ, Grossman J, Sahakian L, Fitzgerald J, Wong WK, Lourenco E, Ragavendra N, Charles-Schoeman C, Gorn A, Karpouzas G, Taylor M, Watson K, Weisman M, Wallace DJ, Hahn BH (2013) A panel of biomarkers is associated with increased risk for the presence and progression of atherosclerosis in women with systemic lupus erythematosus. Arthritis Rheum. doi:10.1002/art.38204
Hsu YW, Belcher BR, Ventura EE, Byrd-Williams CE, Weigensberg MJ, Davis JN, McClain AD, Goran MI, Spruijt-Metz D (2011) Physical activity, sedentary behavior, and the metabolic syndrome in minority youth. Med Sci Sports Exerc 43(12):2307–2313
Rosenson RS, Brewer HB Jr, Davidson WS, Fayad ZA, Fuster V, Goldstein J, Hellerstein M, Jiang XC, Phillips MC, Rader DJ, Remaley AT, Rothblat GH, Tall AR, Yvan-Charvet L (2012) Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125(15):1905–1919. doi:10.1161/CIRCULATIONAHA.111.066589
Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ (2004) High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol 24(11):2181–2187. doi:10.1161/01.ATV.0000146325.93749.a8
Durstine JL, Grandjean PW, Davis PG, Ferguson MA, Alderson NL, DuBose KD (2001) Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis. Sports Med 31(15):1033–1062
Kokkinos PF, Narayan P, Colleran JA, Pittaras A, Notargiacomo A, Reda D, Papademetriou V (1995) Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension. N Engl J Med 333(22):1462–1467. doi:10.1056/NEJM199511303332204
Zmuda JM, Yurgalevitch SM, Flynn MM, Bausserman LL, Saratelli A, Spannaus-Martin DJ, Herbert PN, Thompson PD (1998) Exercise training has little effect on HDL levels and metabolism in men with initially low HDL cholesterol. Atherosclerosis 137(1):215–221
Iborra RT, Ribeiro IC, Neves MQ, Charf AM, Lottenberg SA, Negrao CE, Nakandakare ER, Passarelli M (2008) Aerobic exercise training improves the role of high-density lipoprotein antioxidant and reduces plasma lipid peroxidation in type 2 diabetes mellitus. Scand J Med Sci Sports 18(6):742–750. doi:10.1111/j.1600-0838.2007.00748.x
Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM (2007) Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism 56(4):444–450. doi:10.1016/j.metabol.2006.10.019
Lehmann R, Engler H, Honegger R, Riesen W, Spinas GA (2001) Alterations of lipolytic enzymes and high-density lipoprotein subfractions induced by physical activity in type 2 diabetes mellitus. Eur J Clin Invest 31(1):37–44
Greene NP, Martin SE, Crouse SF (2012) Acute exercise and training alter blood lipid and lipoprotein profiles differently in overweight and obese men and women. Obesity (Silver Spring) 20(8):1618–1627. doi:10.1038/oby.2012.65
Volkmann ER, Grossman JM, Sahakian LJ, Skaggs BJ, FitzGerald J, Ragavendra N, Charles-Schoeman C, Chen W, Gorn A, Karpouzas G, Weisman M, Wallace DJ, Hahn BH, McMahon M (2010) Low physical activity is associated with proinflammatory high-density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 62(2):258–265. doi:10.1002/acr.20076
Miossi R, Benatti FB, Luciade de Sa Pinto A, Lima FR, Borba EF, Prado DM, Perandini LA, Gualano B, Bonfa E, Roschel H (2012) Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care Res (Hoboken) 64(8):1159–1166. doi:10.1002/acr.21678
Prado DM, Benatti FB, de Sa-Pinto AL, Hayashi AP, Gualano B, Pereira RM, Sallum AM, Bonfa E, Silva CA, Roschel H (2013) Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial. Arthritis Res Ther 15(2):R46. doi:10.1186/ar4205
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35(6):630–640
Cohen J (1998) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale
Cairoli E, Rebella M, Danese N, Garra V, Borba EF (2012) Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect. Lupus 21(11):1178–1182. doi:10.1177/0961203312450084
Asztalos BF, de la Llera-Moya M, Dallal GE, Horvath KV, Schaefer EJ, Rothblat GH (2005) Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux. J Lipid Res 46(10):2246–2253. doi:10.1194/jlr.M500187-JLR200
Kontush A, Chapman MJ (2010) Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities. Curr Opin Lipidol 21(4):312–318. doi:10.1097/MOL.0b013e32833bcdc1
Kontush A, Therond P, Zerrad A, Couturier M, Negre-Salvayre A, de Souza JA, Chantepie S, Chapman MJ (2007) Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities. Arterioscler Thromb Vasc Biol 27(8):1843–1849. doi:10.1161/ATVBAHA.107.145672
Hodis HN, Quismorio FP Jr, Wickham E, Blankenhorn DH (1993) The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus. J Rheumatol 20(4):661–665
Wahren-Herlenius M, Dorner T (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382(9894):819–831. doi:10.1016/S0140-6736(13)60954-X
Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, Abdel-Khalek E, El-Shafey EM, Abo-Zenah H (2006) Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 35(3–4):148–153. doi:10.1016/j.cyto.2006.07.023
Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D (1992) Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52(15):4113–4116
Semb H, Peterson J, Tavernier J, Olivecrona T (1987) Multiple effects of tumor necrosis factor on lipoprotein lipase in vivo. J Biol Chem 262(17):8390–8394
Field FJ, Watt K, Mathur SN (2010) TNF-alpha decreases ABCA1 expression and attenuates HDL cholesterol efflux in the human intestinal cell line Caco-2. J Lipid Res 51(6):1407–1415. doi:10.1194/jlr.M002410
Ribeiro IC, Iborra RT, Neves MQ, Lottenberg SA, Charf AM, Nunes VS, Negrao CE, Nakandakare ER, Quintao EC, Passarelli M (2008) HDL atheroprotection by aerobic exercise training in type 2 diabetes mellitus. Med Sci Sports Exerc 40(5):779–786. doi:10.1249/MSS.0b013e3181632d2d
Kathiresan S, Otvos JD, Sullivan LM, Keyes MJ, Schaefer EJ, Wilson PW, D’Agostino RB, Vasan RS, Robins SJ (2006) Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study. Circulation 113(1):20–29. doi:10.1161/CIRCULATIONAHA.105.567107
Williams K, Sniderman AD, Sattar N, D’Agostino R Jr, Wagenknecht LE, Haffner SM (2003) Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 108(19):2312–2316. doi:10.1161/01.CIR.0000097113.11419.9E
Cooper R, Kuh D, Hardy R (2010) Objectively measured physical capability levels and mortality: systematic review and meta-analysis. BMJ 341:c4467. doi:10.1136/bmj.c4467
Acknowledgments
The authors are supported by Fundação de Amparo a Pesquisa do Estado de São Paulo (2011/24093-2), Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior (12824-13-5 for FBB). The authors are grateful to Fabiana Ferreira for technical assistance.
Conflict of interest
The authors also declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Benatti, F.B., Miossi, R., Passareli, M. et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatol Int 35, 61–69 (2015). https://doi.org/10.1007/s00296-014-3081-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-014-3081-4